MENU

RVNC Revance Therapeutics Forecast, Technical & Fundamental Analysis

a developer of drugs

Industry Biotechnology
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RVNC is expected to report earnings to fall 37.93% to -36 cents per share on August 06

Revance Therapeutics RVNC Stock Earnings Reports
Q2'24
Est.
$-0.36
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.03
Q3'23
Missed
by $0.92
Q2'23
Missed
by $0.17
The last earnings report on May 09 showed earnings per share of -57 cents, missing the estimate of -55 cents. With 1.66M shares outstanding, the current market capitalization sits at 409.44M.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIVZX29.810.09
+0.30%
JPMorgan U.S. Applied Data Sci Val R2
UGPSX16.96N/A
N/A
ProFunds UltraChina Service
JSMGX27.91N/A
N/A
Janus Henderson Triton I
IYBIX22.42-0.04
-0.18%
Delaware Ivy Balanced Fund Class I
WINIX9.13-0.04
-0.44%
Wilmington International Institutional

RVNC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RVNC has been loosely correlated with ABCL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RVNC jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVNC
1D Price
Change %
RVNC100%
-4.33%
ABCL - RVNC
47%
Loosely correlated
+2.99%
DNA - RVNC
46%
Loosely correlated
+11.09%
NTLA - RVNC
46%
Loosely correlated
+3.20%
ADPT - RVNC
43%
Loosely correlated
+4.08%
XERS - RVNC
42%
Loosely correlated
+5.81%
More